# Luciano J. Costa

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/luciano-j-costa/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,171 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 61 |
| i10-index | 214 |
| Last Known Institution | University of Alabama at Birmingham |
| OpenAlex ID | https://openalex.org/A5005850190 |
| ORCID iD | https://orcid.org/0000-0001-5362-2469 |
| Works | 605 |

## Researcher papers

- [Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma](https://scholariq.org/papers/ide-cel-or-standard-regimens-in-relapsed-and-refractory-multiple-myeloma/)
- [Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial](https://scholariq.org/papers/daratumumab-lenalidomide-bortezomib-and-dexamethasone-for-transplant-eligible/)
- [Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma](https://scholariq.org/papers/oral-selinexor-dexamethasone-for-triple-class-refractory-multiple-myeloma/)
- [Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma](https://scholariq.org/papers/talquetamab-a-t-cell-redirecting-gprc5d-bispecific-antibody-for-multiple-myeloma/)
- [Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/management-of-immunotherapy-related-toxicities-version-1-2019-nccn-clinical/)
- [NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-management-of-immunotherapy-related-toxicities-version/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Researcher university

- [University of Alabama at Birmingham](https://scholariq.org/institutions/university-of-alabama-at-birmingham/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.